PTX-271

N/A

Report date: 2023/03/12 14:49:28
NME

Base Information

Drug NamePTX-271
Drug Alias NamePTX-271
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitors
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsSkin Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPalvella Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPalvella Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSkin Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A